Announcements

A Form 4 filed with the SEC on September 10, 2026 discloses that Bryan Leach, CEO, President, Director, and 10% Owner of Ibotta, Inc. (NASDAQ:IBTA), exercised stock options and sold Class A Common Stock on September 8 and 9, 2026 pursuant to a Rule …

Director Charlene Barshefsky filed a Form 4 with the SEC on September 10, 2026, disclosing the exercise of stock options and a subsequent sale of Class A Common Stock of Estee Lauder Companies Inc. (NYSE:EL) on September 9, 2026.

Kevin Waters, Executive Vice President and CFO of PROCEPT BioRobotics Corp (NASDAQ:PRCT), filed a Form 4 on September 10, 2026, disclosing the sale of 373 shares of common stock on September 9, 2026, as part of the company's sell-to-cover process for tax withholding obligations.

Barry L. Templin, Executive Vice President and Chief Technology Officer of PROCEPT BioRobotics Corp (NASDAQ:PRCT), filed a Form 4 on September 10, 2026, disclosing the sale of 373 shares of common stock on September 9, 2026, in connection with the vesting of restricted stock …

Alaleh Nouri, Executive Vice President, Chief Legal Officer, and Corporate Secretary of PROCEPT BioRobotics Corp (NASDAQ:PRCT), filed a Form 4 on September 10, 2026, disclosing the sale of 297 shares of common stock on September 9, 2026, in connection with a tax withholding obligation.

Amir Cohen, Chief Accounting Officer of Strata Critical Medical, Inc., filed a statement of changes in beneficial ownership on September 10, 2026, reporting a transaction dated September 8, 2026.

Louis R. Verdetto, CEO of Clinical Services at Strata Critical Medical, Inc. (NASDAQ:SRTA), filed a Form 4 on September 10, 2026, disclosing a share withholding transaction dated September 8, 2026, related to the vesting of restricted stock units.